REQUEST A DEMO
Total
USD $0.00
Search more companies

Antila Lifesciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Antila Lifesciences Private Limited Profile Updated: February 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Antila Lifesciences Private Limited is an unlisted company, incorporated on 21/12/2010. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24230GJ2010PTC063306 and registration number is 063306. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Navrangpura Ahmedabad
Ahmedabad; Gujarat; Postal Code: 380009

Contact Details: Purchase the Antila Lifesciences Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Antila Lifesciences Private Limited report to view the information.
Registered Capital:
Purchase the Antila Lifesciences Private Limited report to view the information.
Incorporation Date:
December 21, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
33.4%
Purchase this report to view the information.
33.3%
Purchase this report to view the information.
33.3%
Company Performance
Financial values in the chart are available after Antila Lifesciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
98.97%
Total operating revenue
99.8%
Operating profit (EBIT)
109.39%
EBITDA
111.87%
Net Profit (Loss) for the Period
146.55%
Total assets
41.91%
Total equity
81.37%
Operating Profit Margin (ROS)
0.23%
Net Profit Margin
0.65%
Return on Equity (ROE)
11.86%
Debt to Equity Ratio
5.88%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?